<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="75531">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01880944</url>
  </required_header>
  <id_info>
    <org_study_id>B-1304-199-003</org_study_id>
    <nct_id>NCT01880944</nct_id>
  </id_info>
  <brief_title>Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study</brief_title>
  <official_title>Evaluation of Usefulness of Contrast Enhanced MRI in Evaluation of Spine Trauma: Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <authority>Korea: Ministry of Food and Drug Safety</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Non-contrast MRI with T2 fat suppression has been a useful imaging modality in evaluation
      spinal trauma.

      However, the role of contrast enhancement has not investigated in patients with spinal
      trauma.

      Therefore, this prospective study aims to evaluate the usefulness of contrast enhanced MRI
      for spinal trauma W/U clinically.

      The study hypothesis is that there is no additional gain in addition of contrast enhanced
      study to routine non-contrast MRI.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">December 2015</completion_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <target_duration>2 Months</target_duration>
  <primary_outcome>
    <measure>The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The rate (%) of change of treatment option between non-surgery vs. surgery, after review of enhanced MRI finding, compared with non-enhanced MRI only</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Confidence level</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Confidence level (1, definitely negative; 2, probably negative; 3, equivocal; 4, probably positive; 5, definitely positive) for lesion of spinal body, posterior compartment, soft tissue (posterior ligamentous complex of thoracolumbar spine and discoligamentous complex of cervical spine), spinal cord, and epidural/subdural hematoma/hemorrhage</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic accuracy of non-enhanced and enhanced MRI</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Diagnostic accuracy of non-enhanced and enhanced MRI in patients with operations for each anatomical lesion (e.g. fracture of body, fracture of posterior compartment, soft tissue injury, cord injury, and epidural/subdural hematoma)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inter- and intra-reader agreement of confidence level</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Inter- and intra-reader agreement of confidence level between non-enhanced and enhanced MRI</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Prognostic value of enhanced MRI</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Prognostic value of enhanced MRI, compared with non-enhanced MRI, based on clinical feature during follow-up period: TLICS(thoracolumbar injury classification and severity score) or SLIC(subaxial cervical injury classification system)score for non-surgery group vs. surgery group</description>
  </other_outcome>
  <other_outcome>
    <measure>The rate (%) of change of treatment plan</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The rate (%) of change of treatment plan between posterior vs. anterior vs. anterior &amp; posterior approaches, after review of enhanced MRI finding, compared with non-enhanced MRI only</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Trauma</condition>
  <arm_group>
    <arm_group_label>ER-spine trauma</arm_group_label>
    <description>patients with spinal trauma, who initially visits in emergency room</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OUT-spine trauma</arm_group_label>
    <description>patients with spinal trauma, who initially visits in outpatient clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NC-MRI, CE-MRI</intervention_name>
    <description>non-contrast spine MRI(NC-MRI) contrast-enhanced spine MRI(CE-MRI)</description>
    <arm_group_label>ER-spine trauma</arm_group_label>
    <arm_group_label>OUT-spine trauma</arm_group_label>
    <other_name>non-contrast spine MRI(NC-MRI)</other_name>
    <other_name>contrast-enhanced spine MRI(CE-MRI)</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        300 patients that fulfilled the following criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients who provided the informed consent

          2. Patients with spinal trauma

          3. Patients with age of 19 years or more

        Exclusion Criteria:

          1. Relative contraindication of MR contrast

               -  previous history of any adverse event after injection of magnetic resonance
                  contrast

               -  pregnant or breast-feeding state

               -  within 2 weeks after liver transplantation

               -  epileptic disorder

          2. Patients impossible with follow-up period of at least 2 months clinically

          3. Patients with severely impaired renal function of estimated glomerular filtration
             rate (GFR) &lt; 30 mL/min/1.73m2 and/or on dialysis

          4. patients with age less than 19 years
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guen Young Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guen Young Lee, MD</last_name>
    <phone>82-31-787-7630</phone>
    <email>netty0523@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Joon Woo Lee, MD, PhD</last_name>
    <phone>82-31-787-7616</phone>
    <email>joonwoo2@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Guen Young Lee</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyenggi-do</state>
        <zip>463-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guen Young Lee, MD</last_name>
      <phone>82-31-787-7630</phone>
      <email>netty0523@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Joon Woo Lee, MD</last_name>
      <phone>82-31-787-7616</phone>
      <email>joonwoo2@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>763-707</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guen Young Lee, MD</last_name>
      <phone>82-31-787-7630</phone>
      <email>netty0523@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Guen Young Lee, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 1, 2013</lastchanged_date>
  <firstreceived_date>June 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Guen Young Lee</investigator_full_name>
    <investigator_title>Cinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>spine</keyword>
  <keyword>trauma</keyword>
  <keyword>MRI</keyword>
  <keyword>contrast</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
